Read More

Cardinal Health Updated FY24 Adj EPS Guidance to High End of $6.75-$7.00 Vs $6.95 Est, Sees Execution of a New $250M Accelerated Share Repurchase Program in Q2, Reiterated its Long-Term Targets Reflecting 12%-14% Growth of Adj EPS

Fiscal 24 outlook update The company updated fiscal year 2024 non-GAAP diluted EPS guidance to the high end of its $6.75 to $7.00 range. This update is driven by anticipated

CAH

Read More

TechPrecision Provides Update On Status Of Votaw Acquisition; Announces Expiration Of 45-Day Diligence Period During Which It Could Have Terminated Its Previously Disclosed Stock Purchase Agreement Related To The Acquisition

Today, TechPrecision Corporation (NASDAQ:TPCS) ("TechPrecision" or "we," "us" or "our") announced the expiration of the 45-day diligence period during which it could have terminated its previously disclosed Stock

TPCS